sofosbuvir/ledipasvir

DRUG2 trials

Sponsors

University of Texas Southwestern Medical Center, Partners in Health

Conditions

Chronic Hepatitis CLiver Disease

Phase 4

Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study

TerminatedNCT02717949

University of Texas Southwestern Medical CenterLiver Disease

Start: 2016-02-25End: 2017-07-18Updated: 2019-01-08

Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World

CompletedNCT02964091

Partners in HealthChronic Hepatitis C

Start: 2016-10-31End: 2020-08-28Updated: 2021-09-21

Related Papers

Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial.

2018-12-1164 citations